January/February 2010




Advancements in MS Therapy

New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.

By Paul Winnington, Editorial Director


EMG and Nerve Conduction Studies in Clinical Practice

Electrodiagnostic studies are helpful in evaluating weakness, muscle wasting, and sensory symptoms. More specific questions may allow more detailed and directed conclusions.

By Rossitza I. Chichkova, MD, MS and Lara Katzin, MD

Case Report: Neurofibromatosis Involving the Fibula in an Adult Patient

By Julieanne P. Sees, DO and Joseph N. Daniel, DO


In The News

Editor's Message

By Pau Winnington, Editorial Director.

Dementia Insights: OSA: Cognitive Consequences and Treatment of the Normal Population or those with AD

There’s clear evidence of a link between sleep disturbance and cognitive function. A specialist explores implications for patient management.

By Ronald Devere, MD

Therapeutics Q&A: Abobotulinum Toxin in Clinical Practice

The newest formulation of botulinum toxin type A expands the treatment menu.

By Zac Haughn, Senior Associate Editor

Expert Opinion: In Search of the Cerebral Funny Bone: Brain Deficits and Their Neuropsychological Correlates with Humor

Trauma or other brain deficits can impact the patient’s ability to recognize and respond to humor.

By Jessica Norman, MS, Joely P. Esposito, PsyD, Steven Mandel, MD, and Edward E. Maitz, PhD

Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.